The Impact of Brexit on the Life Sciences Industry
With less than six months to go until Britain's legal exit from the EU on 29 March 2019, and a no deal scenario very much still a possible outcome, life sciences companies need to have a plan in place accounting for every possibility. A no deal scenario would have a significant impact on both the EU and UK markets and may result in:
• Medicines batch tested and released in the UK not able to be sold within the EU
• Disruption to clinical trials due to issues with IMP or comparator product supply
• Confusion over the status of EU nationals resulting in gap in healthcare staff
• Delays in the delivery of raw materials and packaging causing stock outs of finished goods
• If EMA approval not valid in UK, pharma companies may not seek approval in the UK for new drugs
Join HBA London, Four Health Media and a fantastic panel of speakers from across the industry for a focused discussion on how Brexit will affect the UK and EU life sciences industries.
Agenda
8:30 - 9:30 AM Registration and networking over breakfast
9:30 - 11:00 AM Brexit panel and Q & A
11:00 - 11:30 AM Wrap up and networking
Special instructions: Closest station: London Bridge
Registration information
Event is open to: HBA members and nonmembers
Online registration deadline: 6 November 2018
Onsite (walk-in) registration: Is NOT allowed
This event is nonrefundable.
Learning Objectives
Hear about the current thinking on what impact Brexit will have on the UK and EU life sciences companies.
Featured Speakers
Angela
Bowden
Brexit lead for life sciences and consumer products ,
EY (Ernst & Young) - US
Sarah
Jones
Managing director,
Four Health Public Affairs
Pricing
Regular registration | €26.00 / $30.00 | €39.00 / $45.00 |
Members receive up to 50 percent discount
Event Policies
Photography Policy
By registering for this event, you acknowledge that you may be photographed, videotaped, and/or audio-taped during the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion, and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.
COVID-19 Policy
The HBA requires that all persons who participate in in-person events do so at their own risk and that each participant agrees to the following agreement before taking part in the activity and urges all participants to act in such a manner as to protect their own safety and the safety of others.
By registering for this event, I fully understand that my participation in the program is purely voluntary. I desire to participate and agree to act reasonably and prudently under the circumstances. I further understand that any HBA volunteers participating in the activity will act individually and will not represent the HBA. As a condition to my participation the activity, I waive and release the HBA and their officers, employees, and agents from any claim that I may have for any damage to property or injury to my person that may result in whole or in part from my participation.
Special Needs Policy
The HBA will make reasonable modifications to policies and programs to ensure that people with special needs can enjoy all of its programs. Contact us if you require special accommodations for this event.